Objective: Added transforming growth factor beta (TGFbeta) inhibits the proliferation of immature cardiomyocytes. We have now examined the hypothesis that suppression of endogenous TGFbeta signaling will boost the proliferative response (DNA synthesis) of cardiac myocytes to serum and/or to the mitogenic factor fibroblast growth factor-2 (FGF-2).
Methods And Results: Overexpression of a kinase-deficient TGFbeta type II receptor (TGFbetaRIIDeltaKD) resulted in a 2.
Fibroblast growth factor 2 (FGF-2) is a multifunctional mitogen present in CUG-and AUG-initiated forms, referred to as 'hi' and 'lo' FGF-2, respectively. We have used an adenoviral vector to express the predominantly nuclear human 'hi' FGF-2 and examined the relationship between expression levels, mitotic entry, cell number and chromatin compaction of cardiac myocytes, over 1-3 days in culture. At a multiplicity of infection (m.
View Article and Find Full Text PDF